Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 181, Issue 1, Pages 155-165
Publisher
Springer Science and Business Media LLC
Online
2020-04-01
DOI
10.1007/s10549-020-05614-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis.
- (2019) R. Donald Harvey et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
- (2019) Maya Guglin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
- (2018) Elisa Gobbini et al. EUROPEAN JOURNAL OF CANCER
- Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
- (2017) Peter A Henriksen HEART
- Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2–Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study
- (2017) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
- (2017) Ian E Krop et al. LANCET ONCOLOGY
- Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework
- (2017) Darius N. Lakdawalla et al. VALUE IN HEALTH
- Inclusion of elderly patients in oncology clinical trials
- (2016) O. Le Saux et al. ANNALS OF ONCOLOGY
- Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study
- (2016) Inna Y. Gong et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeted Therapies in Older Adults With Breast Cancer: What Do We Know?
- (2016) Shlomit Strulov Shachar et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
- (2016) Anthony F. Yu et al. ONCOLOGIST
- Efficacy-effectiveness gap as an obstacle to translating clinical trials to clinical practice
- (2015) Amirrtha Srikanthan et al. EUROPEAN JOURNAL OF CANCER
- Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials
- (2014) Joseph M. Unger et al. JNCI-Journal of the National Cancer Institute
- Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
- (2013) David Miles et al. BREAST CANCER RESEARCH AND TREATMENT
- Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer
- (2013) Mariana Chavez-MacGregor et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2013) S. M. Swain et al. ONCOLOGIST
- Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis
- (2012) L. Tarantini et al. ANNALS OF ONCOLOGY
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
- (2012) Patricia Guyot et al. BMC Medical Research Methodology
- Impact of Breast Cancer Subtypes and Treatment on Survival: An Analysis Spanning Two Decades
- (2012) R. Haque et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effectiveness of Bevacizumab With First-Line Combination Chemotherapy for Medicare Patients With Stage IV Colorectal Cancer
- (2012) Jeffrey A. Meyerhardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
- (2012) Jersey Chen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
- (2012) Laura Biganzoli et al. LANCET ONCOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
- (2011) Luigi Tarantini et al. JOURNAL OF CARDIAC FAILURE
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Subtypes and the Risk of Local and Regional Relapse
- (2010) K. David Voduc et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998–2005
- (2010) Xianglin L. Du et al. MEDICAL ONCOLOGY
- Fifteen-year trends in metastatic breast cancer survival in Greece
- (2009) U. Dafni et al. BREAST CANCER RESEARCH AND TREATMENT
- Generalizing the Results of Cancer Clinical Trials
- (2009) Ralph M. Meyer JOURNAL OF CLINICAL ONCOLOGY
- Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment Setting
- (2009) Elizabeth B. Lamont et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search